100 related articles for article (PubMed ID: 25393149)
1. Involvement of MEK/ERK1/2 and PI3K/Akt pathways in the refractory behavior of GH3B6 pituitary tumor cells to the inhibitory effect of TGFβ1.
Petiti JP; Sosa Ldel V; Sabatino ME; Vaca AM; Gutiérrez S; De Paul AL; Torres AI
Endocrinology; 2015 Feb; 156(2):534-47. PubMed ID: 25393149
[TBL] [Abstract][Full Text] [Related]
2. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
[TBL] [Abstract][Full Text] [Related]
3. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
[TBL] [Abstract][Full Text] [Related]
5. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
6. Trastuzumab inhibits pituitary tumor cell growth modulating the TGFB/SMAD2/3 pathway.
Petiti JP; Sosa LDV; Picech F; Moyano Crespo GD; Arevalo Rojas JZ; Pérez PA; Guido CB; Leimgruber C; Sabatino ME; García P; Bengio V; Papalini FR; Estario P; Berhard C; Villarreal M; Gutiérrez S; De Paul AL; Mukdsi JH; Torres AI
Endocr Relat Cancer; 2018 Oct; 25(10):837-852. PubMed ID: 29875136
[TBL] [Abstract][Full Text] [Related]
7. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
Wang Z; Jiang C; Ganther H; Lü J
Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells.
Romano D; Pertuit M; Rasolonjanahary R; Barnier JV; Magalon K; Enjalbert A; Gerard C
Endocrinology; 2006 Dec; 147(12):6036-45. PubMed ID: 16935846
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion.
Zhou J; Du T; Li B; Rong Y; Verkhratsky A; Peng L
ASN Neuro; 2015; 7(5):. PubMed ID: 26442853
[TBL] [Abstract][Full Text] [Related]
10. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
11. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
Lee MY; Jo SD; Lee JH; Han HJ
J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
[TBL] [Abstract][Full Text] [Related]
12. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
13. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
[TBL] [Abstract][Full Text] [Related]
14. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
Tandon M; Chen Z; Pratap J
J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
[TBL] [Abstract][Full Text] [Related]
15. γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways.
Hafner A; Obermajer N; Kos J
Biochem J; 2012 Apr; 443(2):439-50. PubMed ID: 22257123
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
[TBL] [Abstract][Full Text] [Related]
18. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
19. Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages.
Sun J; Ramnath RD; Tamizhselvi R; Bhatia M
FASEB J; 2009 Apr; 23(4):997-1010. PubMed ID: 19029199
[TBL] [Abstract][Full Text] [Related]
20. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]